In VSMCs, IL-1β activates NF-κB leading to Nox1, VCAM-1 and iNOS expression. The TPr agonist U46619 augments both Nox1 and VCAM-1 expression through activation of JNK/AP-1 signaling, but inhibits iNOS expression induced by IL-1β. Adhesion of monocytes to VSMC is regulated by the balance of VCAM-1 expression, and nitric oxide (NO) and superoxide anion (O2.−) production. Activation of TPr results in increased expression of Nox1 that enhances superoxide generation, which inactivates nitric oxide produced by iNOS, likely forming peroxynitrite (OONO−), and contributes to enhanced monocyte adhesion.